目次

Chapter- 1: Introduction
Diabetes
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown

Chapter- 2: Summary and Highlights
Market Overview
Significant Developments and Trends

Chapter- 3: Market Overview
What is Diabetes?
Types of Diabetes
Epidemiology of Diabetes
Market Factors Driving the Growth and Development of the Market

Chapter- 4: Global Market for Diabetes Therapeutics
Overview
Classification and Types of Antidiabetic Medications
Facing the Patent Cliff
Latest Technological Advances, Developments and Product Pipelines for Diabetic Medications

Chapter- 5: Global Market for Diabetes Monitoring Devices and Accessories
Overview
Self-Monitoring of Blood Glucose (SMBG)
Continuous Glucose Monitoring (CGM) Systems

Chapter- 6: Global Market for Diabetes Delivery Devices by Type
Overview
Insulin Syringes
Insulin Delivery Pen Devices
Insulin Jet Injectors
External Insulin Pumps
Implantable Insulin Pumps
Insulin Inhalers
Insulin Patches
Oral Insulin Delivery

Chapter- 7: Global Market for Diabetes Therapeutics and Diagnostics by End User
Overview

Chapter- 8: Global Market for Diabetes Therapeutics and Diagnostics by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 9: Sustainability in the Market for Diabetes Therapeutics and Diagnostics: An ESG Perspective
Introduction

Chapter- 10: Emerging Technologies
Patient Outcomes Beyond Glucose Control
Diabetes Technology with Digital Health
Growing Trend Toward Oral Antidiabetics
Growing Focus on Accessibility and Affordability of Medicine
Artificial Pancreas

Chapter- 11: M&As and Venture Funding Outlook in the Market
M&A Analysis

Chapter- 12: Competitive Landscape
Recent Strategic Initiatives, By Major Players in The Market

Chapter- 13: Company Profiles
77 ELEKTRONIKA KFT.
ABBOTT
ALTUCELL
ASCENSIA DIABETES CARE HOLDINGS AG.
ASTRAZENECA
B. BRAUN SE
BIOCON
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
DANAHER
DEXCOM INC.
EMBECTA CORP.
INSULET CORPORATION.
JOHNSON & JOHNSON SERVICES INC.
LIFESCAN IP HOLDINGS LLC
LILLY
MEDTRONIC
MENARINI GROUP (A. MENARINI DIAGNOSTICS S.R.L)
MERCK & CO. INC.
MERCK KGAA
NEXTCELL PHARMA AB
NIPRO
NOVA BIOMEDICAL
NOVARTIS AG
NOVO NORDISK A/S
ROCHE (F. HOFFMANN-LA ROCHE LTD)
SANOFI
TAKEDA PHARMACEUTICAL COMPANY LIMITED.
TANDEM DIABETES CARE INC.
TERUMO CORPORATION
YPSOMED AG

Chapter- 14: Appendix
Government Regulatory Agencies and Professional Organizations